NCT06316388

Outcomes After Vitrectomy in Eyes With Tractional Diabetic Macular Edema

Name: Clinical Trial NCT06316388
Creator: Rehab Azzam
Keywords: Diabetic Macular Edema, vitrectomy, procedure, clinical trial

Anatomical and Functional Outcomes After Vitrectomy in Eyes With Tractional Diabetic Macular Edema

Rehab Azzam·ClinicalTrials.gov·procedureNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Diabetic Macular Edema
Drug/Device/Intervention: vitrectomy
Study type: Observational
Intervention type: procedure

Sponsor & location

Primary sponsor: Rehab Azzam
Funder: Assiut University

Timeline & enrollment

Phase: N/A
Start date: Mar 10, 2024
End date: Mar 11, 2025
Enrollment: 21 participants

Primary outcome

assessment the outcomes of vitrectomy on retinal function in patients with tractional diabetic macular edema,assessment the outcomes of vitrectomy on retinal anatomy in patients with tractional diabetic macular edema

Summary

1. assessment the outcomes of vitrectomy on retinal function by mf-ERG (multifocal electroretinogram) and anatomy by OCT (optical coherence tomography) in patients with tractional diabetic macular edema (TDME) .  2. To correlate the postoperative corrected distance visual acuity (CDVA) with the mf-ERG and OCT findings following vitrectomy surgery for TDME.

ICD-10 classifications

Diabetic retinopathyOther specified diabetes mellitus with ophthalmic complicationsUnspecified diabetes mellitus with ophthalmic complicationsDiabetic cataractType 2 diabetes mellitus with ophthalmic complications

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06316388
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06316388 through Pure Global AI's free database. This phase not specified trial is sponsored by Rehab Azzam and is currently Not yet recruiting. The study focuses on Diabetic Macular Edema. Target enrollment is 21 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.